RxDoctor Payments DataLook up a doctor →

Omar Almousalli, MD

Cardiovascular Disease · Festus, MONPI 1134161904

Payments from drug & device makers

$690,189in general payments, 2019–2025

Across 816 payments — averaging $845.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • American Regent$510K
  • Amgen$77K
  • Boehringer Ingelheim International GmbH$70K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$13K
  • E.r. Squibb & Sons, L.L.C.$4K
  • Boehringer Ingelheim$2K
  • plus $14K from 47 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
American Regent19$509,836
Amgen107$77,475
Boehringer Ingelheim International GmbH7$69,860
Boehringer Ingelheim Pharma GmbH & Co.kg2$13,012
E.r. Squibb & Sons, L.L.C.27$3,960
Boehringer Ingelheim59$2,278
Merck43$1,757
Novartis110$1,564
Johnson & Johnson76$1,069
Biotronik Inc.2$939
Abiomed9$891
Abbott15$818
Esperion Therapeutics, Inc.75$753
Sanofi-aventis U.S. LLC29$731
AstraZeneca35$728
Boston Scientific22$664
Pfizer39$485
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)23$380
Shockwave Medical, Inc7$319
Medtronic(2 entities)6$234
Scpharmaceuticals Inc.6$221
Novo Nordisk12$206
Bayer10$197
Kiniksa Pharmaceuticals, Ltd.7$181
Philips North America LLC3$173
Regeneron Healthcare Solutions, Inc.8$167
Vifor Pharma, Inc.8$140
Globus Medical1$132
Kiniksa Pharmaceuticals International, PLC4$96
Kowa Pharmaceuticals America, Inc.7$95
Penumbra, Inc.1$87
Lexicon Pharmaceuticals, Inc.3$80
Intuitive Surgical1$75
Otsuka America Pharmaceutical, Inc.4$65
Actelion Pharmaceuticals US, Inc.4$56
Cvrx, Inc.2$56
Gilead4$48
Stryker2$46
Cardiovascular Systems Inc.2$42
Angiodynamics, Inc.1$35
Chiesi USA, Inc.2$34
Daiichi Sankyo Inc.1$30
Heartflow, Inc.1$24
Covidien LP1$24
CMP Pharma, Inc.1$19
Koya Medical, Inc.1$18
Aegerion Pharmaceuticals, Inc.1$18
Kestra Medical Technology Services, Inc.1$15
Cook Medical LLC1$15
Inari Medical, Inc.1$13
Medicure Pharma Inc.1$13
Bardy Diagnostics, Inc.1$11
Sanofi1$8

How this compares

$690,189 in reported general payments places this provider in the 95th percentile of 391 cardiovascular disease providers in Missouri.

See all cardiovascular disease providers in Missouri →

Medicare billing

Part B allowed, 2024
$453,474
Medicare patients
1,535
Services billed
5,570

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Festus

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →